Developers are adopting AI coding assistants at a rapid clip, but a growing body of peer-reviewed research shows that machine ...
Johnson & Johnson has added another piece to the data behind its effort to move Tecvayli into earlier-line therapy for multiple myeloma, including the first relapse setting. In the MajesTEC-9 trial, ...